ACE-inhibition for secondary prevention of cardiovascular events--should we change our recommendation after PEACE? [electronic resource]
- Cardiovascular drugs and therapy Feb 2006
- 11-2 p. digital
Publication Type: Comment; Editorial
0920-3206
10.1007/s10557-006-7297-8 doi
Angiotensin-Converting Enzyme Inhibitors--therapeutic use Cardiovascular Diseases--prevention & control Humans Meta-Analysis as Topic Practice Guidelines as Topic Randomized Controlled Trials as Topic Secondary Prevention